Levonorgestrel Apofri (Levonorgestrel)

Levonorgestrel binds to progesterone receptors, suppressing the luteinizing hormone surge that triggers ovulation. It also thickens cervical mucus, making it harder for sperm to reach the egg, and modifies the endometrial lining, creating an environment that is unfavorable for implantation of a fertilized egg.

The specific dosing regimen for Levonorgestrel Apofri is determined by a qualified prescriber based on the intended use—whether for routine contraception or as emergency contraception. Healthcare professionals follow established clinical guidelines to select the appropriate dose and timing for each patient.

Levonorgestrel Apofri is not intended for use during an existing pregnancy and should be avoided if pregnancy is confirmed. While limited data exist for breastfeeding, the drug does pass into breast milk in small amounts; therefore, a healthcare provider should evaluate the risk‑benefit ratio before use in nursing mothers.

To order Levonorgestrel Apofri, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levonorgestrel Apofri is a progestogen‑based oral option that is effective when taken within 72 hours after unprotected intercourse. Compared with copper‑IUD insertion, it is less invasive but has a shorter window of maximal efficacy. Compared with ulipristal acetate, levonorgestrel is generally less expensive but may be slightly less effective after 48 hours.

Levonorgestrel Apofri tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light, and keep out of reach of children. Do not store in bathrooms or other humid environments.

Levonorgestrel Apofri is administered orally. For routine contraception, it is taken as directed by a prescriber, typically once daily or as a weekly regimen depending on the product formulation. For emergency use, a single tablet is taken as soon as possible after unprotected intercourse, following the prescriber’s instructions.

Serious risks, though rare, include severe allergic reactions (anaphylaxis), blood clot formation such as deep‑vein thrombosis, and liver dysfunction. Any signs of unusual bleeding, severe abdominal pain, or allergic symptoms should prompt immediate medical evaluation.

Women who are currently pregnant, have a known hypersensitivity to levonorgestrel or any tablet excipients, or have a history of thromboembolic disorders, severe liver disease, or hormone‑sensitive cancers should avoid using Levonorgestrel Apofri unless advised otherwise by a qualified healthcare professional.